Rentokil Initial plc (NYSE:RTO – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the eight research firms that are presently covering the company, Marketbeat reports. Five equities research analysts have rated the stock with a hold rating, one has assigned a buy rating and two have assigned a strong buy rating to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $29.00.
RTO has been the topic of several recent research reports. Redburn Atlantic cut Rentokil Initial from a “buy” rating to a “neutral” rating in a report on Thursday, September 19th. Citigroup raised shares of Rentokil Initial to a “strong-buy” rating in a research note on Friday, December 13th.
Read Our Latest Stock Analysis on Rentokil Initial
Institutional Investors Weigh In On Rentokil Initial
Rentokil Initial Stock Down 2.7 %
NYSE:RTO opened at $23.47 on Monday. The stock’s fifty day moving average price is $25.70 and its two-hundred day moving average price is $27.37. The company has a market cap of $11.85 billion, a price-to-earnings ratio of 16.65, a P/E/G ratio of 7.23 and a beta of 1.08. Rentokil Initial has a 52-week low of $22.40 and a 52-week high of $34.07. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.96 and a current ratio of 1.04.
About Rentokil Initial
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
Read More
- Five stocks we like better than Rentokil Initial
- Basic Materials Stocks Investing
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- Short Selling: How to Short a Stock
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.